ibandronic acid has been researched along with Experimental Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauss, F; Boyce, BF; Dallas, MR; Dallas, SL; Garrett, IR; Mundy, GR; Oyajobi, BO; Radl, J | 1 |
| Asosingh, K; Croucher, PI; Hughes, DE; Lippitt, JM; Rogers, MJ; Russell, RG; Shipman, CM; Van Camp, B; Vanderkerken, K | 1 |
2 other study(ies) available for ibandronic acid and Experimental Neoplasms
| Article | Year |
|---|---|
Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone disease.
Topics: Animals; Bone Neoplasms; Bone Resorption; Diphosphonates; Humans; Ibandronic Acid; Mice; Mice, Inbred C57BL; Multiple Myeloma; Neoplasms, Experimental | 1999 |
The potent bisphosphonate ibandronate does not induce myeloma cell apoptosis in a murine model of established multiple myeloma.
Topics: Animals; Apoptosis; Bone Marrow Cells; Diphosphonates; Ibandronic Acid; Mice; Mice, Inbred C57BL; Multiple Myeloma; Neoplasms, Experimental; Treatment Failure; Tumor Cells, Cultured | 2000 |